Recuro Health · 9 hours ago
Quality Assurance Analyst
Recuro Health is a leading virtual-first care delivery company offering a personalized approach to healthcare. As a Quality Software Assurance Analyst, you will ensure the quality, reliability, and security of telehealth products by developing and executing test plans, identifying defects, and improving testing processes.
Health CareHospitalOutpatient Care
Responsibilities
Conduct in user acceptance testing and verify incoming user issues
Help establish and continuously enhance testing processes and practices to improve software quality and team productivity
Ensure that software complies with industry standards, regulatory requirements, and best practices for telehealth applications
Provide regular reports on testing activities, defect status, and overall quality metrics to stakeholders
Work closely with product managers, developers, and stakeholders to understand software requirements and acceptance criteria
Develop comprehensive test plans and strategies, including the identification of test objectives, scope, approach, and resources required
Create detailed, comprehensive, and well-structured test cases and test scripts based on requirements
Perform different types of testing, such as functional, non-functional, regression, performance, usability, and security testing
Identify, document, and track defects. Collaborate with product managers and developers to resolve issues
Qualification
Required
Proficiency in software testing tools and Scrum Methodology
Experience with exploratory testing and risk-based testing approaches
Strong written, verbal, and interpersonal communication skills
Strong analytical and problem-solving skills
Bachelor's degree or equivalent work experience
Preferred
Familiarity with an automated testing framework
Understanding of telehealth and healthcare software applications
Knowledge of Healthcare Technology Standards and Regulations (HIPAA, HITECH, etc.)
Company
Recuro Health
Recuro Health offers a holistic suite of virtual care services and supplemental benefits.
Funding
Current Stage
Growth StageTotal Funding
$62MKey Investors
ARCH Venture PartnersOklahoma Life Science Fund
2023-04-11Series B· $47M
2022-03-31Convertible Note
2021-11-30Series A
Recent News
Dallas Innovates
2025-09-17
Dallas Innovates
2025-03-14
Microsoft Accelerator Bangalore
2024-11-07
Company data provided by crunchbase